{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:34Z","timestamp":1792785994738,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:00:00Z","timestamp":1557532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Cancer Institute Cancer Center Support","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]},{"name":"Veterinary and Pathology Core Facilities"},{"name":"Flow Cytometry and Cellular Imaging Facility"},{"name":"Proteomics Core, Sequencing and Microarray Facility"},{"name":"Genetically Engineered Mouse Facility"},{"name":"Anderson Cancer Center"},{"DOI":"10.13039\/100001033","name":"Jane Coffin Childs Memorial Fund for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA207204"],"award-info":[{"award-number":["R01CA207204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CPRIT Research Training","award":["CRP170067"],"award-info":[{"award-number":["CRP170067"]}]},{"name":"CPRIT Research Training","award":["RP17067"],"award-info":[{"award-number":["RP17067"]}]},{"name":"CPRIT Research Training","award":["RP140106"],"award-info":[{"award-number":["RP140106"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA138688"],"award-info":[{"award-number":["R01CA138688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RC1CA146299"],"award-info":[{"award-number":["1RC1CA146299"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Research Innovation Spain"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heterogeneous nuclear ribonucleoprotein K (hnRNP\u00a0K) is an RNA-binding protein that is aberrantly expressed in cancers. We and others have previously shown that reduced hnRNP\u00a0K expression downmodulates tumor-suppressive programs. However, overexpression of hnRNP\u00a0K is the more commonly observed clinical phenomenon, yet its functional consequences and clinical significance remain unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical implications of hnRNP\u00a0K overexpression were examined through immunohistochemistry on samples from patients with diffuse large B-cell lymphoma who did not harbor MYC alterations (n\u2009=\u200975). A novel transgenic mouse model that overexpresses hnRNP\u00a0K specifically in B cells was generated to directly examine the role of hnRNP\u00a0K overexpression in mice (three transgenic lines). Molecular consequences of hnRNP\u00a0K overexpression were determined through proteomics, formaldehyde-RNA-immunoprecipitation sequencing, and biochemical assays. Therapeutic response to BET-bromodomain inhibition in the context of hnRNP\u00a0K overexpression was evaluated in vitro and in vivo (n\u2009=\u20093 per group). All statistical tests were two-sided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>hnRNP\u00a0K is overexpressed in diffuse large B-cell lymphoma patients without MYC genomic alterations. This overexpression is associated with dismal overall survival and progression-free survival (P\u2009&amp;lt;\u2009.001). Overexpression of hnRNP\u00a0K in transgenic mice resulted in the development of lymphomas and reduced survival (P\u2009&amp;lt;\u2009.001 for all transgenic lines; Line 171[n\u2009=\u200930]: hazard ratio [HR]\u2009=\u200964.23, 95% confidence interval [CI]\u2009=\u200926.1 to 158.0; Line 173 [n\u2009=\u200931]: HR\u2009=\u200925.27, 95% CI\u2009=\u200910.3 to 62.1; Line 177 [n\u2009=\u200925]: HR\u2009=\u2009119.5, 95% CI\u2009=\u200942.7 to 334.2, compared with wild-type mice). Clinical samples, mouse models, global screening assays, and biochemical studies revealed that hnRNP\u00a0K\u2019s oncogenic potential stems from its ability to posttranscriptionally and translationally regulate MYC. Consequently, Hnrnpk overexpression renders cells sensitive to BET-bromodomain-inhibition in both in vitro and transplantation models, which represents a strategy for mitigating hnRNP\u00a0K-mediated c-Myc activation in patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that hnRNP\u00a0K is a bona fide oncogene when overexpressed and represents a novel mechanism for c-Myc activation in the absence of MYC lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djz078","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T15:23:41Z","timestamp":1556637821000},"page":"95-106","source":"Crossref","is-referenced-by-count":30,"title":["Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas"],"prefix":"10.1093","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-9130","authenticated-orcid":false,"given":"Miguel","family":"Gallardo","sequence":"first","affiliation":[{"name":"Department of Leukemia"},{"name":"H12O-CNIO Haematological Malignancies Clinical Research Unit, Clinical Research Programme, CNIO, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Malaney","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa J L","family":"Aitken","sequence":"additional","affiliation":[{"name":"Department of Leukemia"},{"name":"MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrutant","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Epigenetics and Molecular Carcinogenesis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanzhar","family":"Alybayev","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Han","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R","family":"Pageon","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine and Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxian","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1144-3344","authenticated-orcid":false,"given":"Rodrigo","family":"Jacamo","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun Y","family":"Xu-Monette","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Steinman","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Ju","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma The University of Texas, MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dos","family":"Sarbassov","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Rapado","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4042-1374","authenticated-orcid":false,"given":"Michelle C","family":"Barton","sequence":"additional","affiliation":[{"name":"Department of Epigenetics and Molecular Carcinogenesis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Martinez-Lopez","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso-Ramos","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Leukemia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,11]]},"reference":[{"issue":"2","key":"2020091409441352100_djz078-B1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2014.06.019","article-title":"Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression","volume":"352","author":"Barboro","year":"2014","journal-title":"Cancer Lett"},{"issue":"6","key":"2020091409441352100_djz078-B2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/bies.20048","article-title":"hnRNP K: one protein multiple processes","volume":"26","author":"Bomsztyk","year":"2004","journal-title":"Bioessays"},{"issue":"7","key":"2020091409441352100_djz078-B3","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/jcmm.12999","article-title":"Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer","volume":"21","author":"Chen","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2020091409441352100_djz078-B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2009.01.019","article-title":"MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53","volume":"15","author":"Enge","year":"2009","journal-title":"Cancer Cell"},{"key":"2020091409441352100_djz078-B5","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2016.1164372","article-title":"Aberrant hnRNP K expression: all roads lead to cancer","author":"Gallardo","year":"2016","journal-title":"Cell Cycle"},{"issue":"6","key":"2020091409441352100_djz078-B6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2005.09.032","article-title":"hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage","volume":"123","author":"Moumen","year":"2005","journal-title":"Cell"},{"issue":"7","key":"2020091409441352100_djz078-B7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bjc.6603349","article-title":"Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer","volume":"95","author":"Carpenter","year":"2006","journal-title":"Br J Cancer"},{"issue":"21","key":"2020091409441352100_djz078-B8","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1074\/jbc.M113.466136","article-title":"Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis","volume":"288","author":"Gao","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"2020091409441352100_djz078-B9","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s12032-011-0037-3","article-title":"Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer","volume":"29","author":"Wang","year":"2012","journal-title":"Med Oncol"},{"issue":"15","key":"2020091409441352100_djz078-B10","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1128\/MCB.25.15.6436-6453.2005","article-title":"hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation","volume":"25","author":"Lynch","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2020091409441352100_djz078-B11","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/MCB.02014-06","article-title":"Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site","volume":"27","author":"Adolph","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2020091409441352100_djz078-B12","article-title":"Impact of the Mdm2SNP309-G allele on a murine model of colorectal cancer","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"2020091409441352100_djz078-B13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.189.1.123","article-title":"Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes","volume":"189","author":"Shaw","year":"1999","journal-title":"J Exp Med"},{"issue":"1","key":"2020091409441352100_djz078-B14","doi-asserted-by":"crossref","first-page":"28.","DOI":"10.1186\/s13059-016-0878-3","article-title":"Widespread RNA binding by chromatin-associated proteins","volume":"17","author":"G Hendrickson","year":"2016","journal-title":"Genome Biol"},{"issue":"39","key":"2020091409441352100_djz078-B15","doi-asserted-by":"crossref","first-page":"63504","DOI":"10.18632\/oncotarget.11531","article-title":"Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human","volume":"7","author":"Eason","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"2020091409441352100_djz078-B16","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1158\/0008-5472.CAN-08-1329","article-title":"Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma","volume":"68","author":"Mori","year":"2008","journal-title":"Cancer Res"},{"issue":"12","key":"2020091409441352100_djz078-B17","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1158\/1535-7163.MCT-13-0044","article-title":"Utilization of the E\u03bc-Myc mouse to model heterogeneity of therapeutic response","volume":"13","author":"Rempel","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"2020091409441352100_djz078-B18","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1128\/MCB.00839-06","article-title":"Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis","volume":"26","author":"Wen","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2020091409441352100_djz078-B19","doi-asserted-by":"crossref","first-page":"106.","DOI":"10.1186\/s13046-016-0374-3","article-title":"Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma","volume":"35","author":"Lv","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2020091409441352100_djz078-B20","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/MCB.16.5.2350","article-title":"Heterogeneous nuclear ribonucleoprotein K is a transcription factor","volume":"16","author":"Michelotti","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"34","key":"2020091409441352100_djz078-B21","doi-asserted-by":"crossref","first-page":"24788","DOI":"10.1074\/jbc.M113.496679","article-title":"Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3\u2032-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease","volume":"288","author":"Mikula","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"2020091409441352100_djz078-B22","doi-asserted-by":"crossref","first-page":"51.","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"D1","key":"2020091409441352100_djz078-B23","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2020091409441352100_djz078-B24","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"issue":"24","key":"2020091409441352100_djz078-B25","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2020091409441352100_djz078-B26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2015.118","article-title":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"28","author":"Xu-Monette","year":"2015","journal-title":"Mod Pathol"},{"issue":"39","key":"2020091409441352100_djz078-B27","doi-asserted-by":"crossref","first-page":"8012.","DOI":"10.1038\/sj.onc.1206645","article-title":"Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo","volume":"22","author":"Evans","year":"2003","journal-title":"Oncogene"},{"issue":"7327","key":"2020091409441352100_djz078-B28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"6","key":"2020091409441352100_djz078-B29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3\u00a0ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem Biol"},{"issue":"40","key":"2020091409441352100_djz078-B30","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2020091409441352100_djz078-B31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as\u00a0a therapeutic strategy to target c-myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"issue":"4","key":"2020091409441352100_djz078-B32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ccell.2015.09.001","article-title":"hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies","volume":"28","author":"Gallardo","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"2020091409441352100_djz078-B33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2013-01-479188","article-title":"Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia","volume":"122","author":"Kr\u00f6nke","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2020091409441352100_djz078-B34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/humu.22837","article-title":"GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de\u00a0novo variants in HNRNPK","volume":"36","author":"Au","year":"2015","journal-title":"Hum Mutat"},{"issue":"22","key":"2020091409441352100_djz078-B35","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"2020091409441352100_djz078-B36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.13029","article-title":"Clinical spectrum of Kabuki-like syndrome\u00a0caused by HNRNPK haploinsufficiency","volume":"93","author":"Dentici","year":"2018","journal-title":"Clin Genet"},{"issue":"3","key":"2020091409441352100_djz078-B37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cge.12773","article-title":"A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia","volume":"90","author":"Lange","year":"2016","journal-title":"Clin Genet"},{"key":"2020091409441352100_djz078-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.leukres.2018.11.007","article-title":"Characterization of acute myeloid leukemia with del(9q) \u2013 impact of the genes in the minimally deleted region","volume":"76","author":"Naarmann-de Vries","year":"2019","journal-title":"Leuk Res"},{"issue":"6","key":"2020091409441352100_djz078-B39","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","article-title":"A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulating MYC mRNA translation","volume":"107","author":"Notari","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2020091409441352100_djz078-B40","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1245\/s10434-010-1121-1","article-title":"Higher expression of the heterogeneous nuclear ribonucleoprotein K in melanoma","volume":"17","author":"Wen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2020091409441352100_djz078-B41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.oraloncology.2012.01.005","article-title":"Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma","volume":"48","author":"Wu","year":"2012","journal-title":"Oral Oncol"},{"issue":"5","key":"2020091409441352100_djz078-B42","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/nar\/gkg246","article-title":"Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription","volume":"31","author":"Ritchie","year":"2003","journal-title":"Nucleic Acids Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djz078\/28933732\/djz078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/112\/1\/95\/33745468\/djz078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/112\/1\/95\/33745468\/djz078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:45:03Z","timestamp":1600076703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/112\/1\/95\/5488188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,5,11]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djz078","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,5,11]]}}}